Invivyd (IVVD) is an interesting biotech because it has already received emergency use authorization [EUA] from the FDA for its pre-exposure prophylaxis [PrEP] vaccine candidate PEMGARDA [pemivibart] ...
High-titre convalescent plasma therapy given within a week of symptom onset reduced hospitalisation and death and was well tolerated in immunocompromised patients with mild COVID-19. This randomised ...
Ongoing clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events, no ...
Nov 23 (Reuters) - Merck & Co Inc (MRK.N), opens new tab has agreed to acquire drugmaker OncoImmune in a deal that will give it control of a drug that could help ease symptoms and reduce deaths in ...
NEWTOWN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results